Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleClinical Investigations

Comparison of 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma

Molly P. Hogan, Debra A. Goldman, Brittany Dashevsky, Christopher C. Riedl, Mithat Gönen, Joseph R. Osborne, Maxine Jochelson, Clifford Hudis, Monica Morrow and Gary A. Ulaner
Journal of Nuclear Medicine November 2015, 56 (11) 1674-1680; DOI: https://doi.org/10.2967/jnumed.115.161455
Molly P. Hogan
1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
2Department of Radiology, Weill Cornell Medical College, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Debra A. Goldman
3Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brittany Dashevsky
1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
2Department of Radiology, Weill Cornell Medical College, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher C. Riedl
1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mithat Gönen
3Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Joseph R. Osborne
1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
2Department of Radiology, Weill Cornell Medical College, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maxine Jochelson
1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
2Department of Radiology, Weill Cornell Medical College, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Clifford Hudis
4Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Monica Morrow
5Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gary A. Ulaner
1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
2Department of Radiology, Weill Cornell Medical College, New York, New York
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 56 no. 11 1674-1680
DOI 
https://doi.org/10.2967/jnumed.115.161455
PubMed 
26294295

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication June 1, 2015
  • Accepted for publication August 4, 2015
  • Published online November 2, 2015.

Article Versions

  • previous version (August 20, 2015 - 05:27).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2015 by the Society of Nuclear Medicine and Molecular Imaging, Inc.

Author Information

  1. Molly P. Hogan1,2,
  2. Debra A. Goldman3,
  3. Brittany Dashevsky1,2,
  4. Christopher C. Riedl1,
  5. Mithat Gönen3,
  6. Joseph R. Osborne1,2,
  7. Maxine Jochelson1,2,
  8. Clifford Hudis4,
  9. Monica Morrow5 and
  10. Gary A. Ulaner1,2
  1. 1Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
  2. 2Department of Radiology, Weill Cornell Medical College, New York, New York
  3. 3Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York
  4. 4Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; and
  5. 5Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York
  1. For correspondence or reprints contact: Gary A. Ulaner, Department of Radiology, MSKCC, 1275 York Ave., Box 77, New York, NY 10065. E-mail: ulanerg{at}mskcc.org
View Full Text

Statistics from Altmetric.com

Cited By...

  • 106 Citations
  • 111 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Head-to-Head Evaluation of 18F-FES and 18F-FDG PET/CT in Metastatic Invasive Lobular Breast Cancer
    Gary A. Ulaner, Komal Jhaveri, Sarat Chandarlapaty, Vaios Hatzoglou, Christopher C. Riedl, Jason S. Lewis, Audrey Mauguen
    Journal of Nuclear Medicine 2021 62 3
  • PET/CT for Patients With Breast Cancer: Where Is the Clinical Impact?
    Gary A. Ulaner
    American Journal of Roentgenology 2019 213 2
  • Molecular Classification of Breast Cancer
    Elena Provenzano, Gary A. Ulaner, Suet-Feung Chin
    PET Clinics 2018 13 3
  • Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancer
    K. Van Baelen, T. Geukens, M. Maetens, V. Tjan-Heijnen, C.J. Lord, S. Linn, F.-C. Bidard, F. Richard, W.W. Yang, R.E. Steele, S.J. Pettitt, C. Van Ongeval, M. De Schepper, E. Isnaldi, I. Nevelsteen, A. Smeets, K. Punie, L. Voorwerk, H. Wildiers, G. Floris, A. Vincent-Salomon, P.W.B. Derksen, P. Neven, E. Senkus, E. Sawyer, M. Kok, C. Desmedt
    Annals of Oncology 2022 33 8
  • Expression of Gastrin-Releasing Peptide Receptor in Breast Cancer and Its Association with Pathologic, Biologic, and Clinical Parameters: A Study of 1,432 Primary Tumors
    Clément Morgat, Gaétan MacGrogan, Véronique Brouste, Valérie Vélasco, Nicolas Sévenet, Hervé Bonnefoi, Philippe Fernandez, Marc Debled, Elif Hindié
    Journal of Nuclear Medicine 2017 58 9
  • Whole-Body Characterization of Estrogen Receptor Status in Metastatic Breast Cancer with 16α-18F-Fluoro-17β-Estradiol Positron Emission Tomography: Meta-Analysis and Recommendations for Integration into Clinical Applications
    Brenda F. Kurland, Jay R. Wiggins, Amandine Coche, Charlotte Fontan, Yann Bouvet, Peter Webner, Chaitanya Divgi, Hannah M. Linden
    The Oncologist 2020 25 10
  • Invasive lobular and ductal breast carcinoma differ in immune response, protein translation efficiency and metabolism
    Tian Du, Li Zhu, Kevin M. Levine, Nilgun Tasdemir, Adrian V. Lee, Dario A. A. Vignali, Bennett Van Houten, George C. Tseng, Steffi Oesterreich
    Scientific Reports 2018 8 1
  • Impact of 18F-FDG PET, PET/CT, and PET/MRI on Staging and Management as an Initial Staging Modality in Breast Cancer
    Sangwon Han, Joon Young Choi
    Clinical Nuclear Medicine 2021 46 4
  • Initial Results of a Prospective Clinical Trial of 18F-Fluciclovine PET/CT in Newly Diagnosed Invasive Ductal and Invasive Lobular Breast Cancers
    Gary A. Ulaner, Debra A. Goldman, Mithat Gönen, Hanh Pham, Raychel Castillo, Serge K. Lyashchenko, Jason S. Lewis, Chau Dang
    Journal of Nuclear Medicine 2016 57 9
  • 18F-FDG PET/CT in breast cancer: Evidence-based recommendations in initial staging
    Ana Paula Caresia Aroztegui, Ana María García Vicente, Soledad Alvarez Ruiz, Roberto Carlos Delgado Bolton, Javier Orcajo Rincon, Jose Ramon Garcia Garzon, Maria de Arcocha Torres, Maria Jose Garcia-Velloso
    Tumor Biology 2017 39 10

Article usage

Article usage: August 2015 to April 2025

AbstractFullPdf
Aug 2015311031
Sep 2015169030
Oct 2015108017
Nov 2015116035104
Dec 20154132043
Jan 20162211922
Feb 2016149910
Mar 2016102818
Apr 2016781226
May 2016612129
Jun 2016511220
Jul 201641727
Aug 201628612
Sep 201650510
Oct 201638119
Nov 2016431628
Dec 2016591942
Jan 2017272311
Feb 2017421317
Mar 20172359
Apr 2017422222
May 2017291215
Jun 201733118
Jul 201725920
Aug 201731817
Sep 2017312014
Oct 2017352011
Nov 2017231311
Dec 20172476
Jan 201822611
Feb 201825913
Mar 20182378
Apr 20181957
May 20181666
Jun 201810812
Jul 20181274
Aug 201811105
Sep 20181478
Oct 2018191120
Nov 2018191014
Dec 201813913
Jan 2019172913
Feb 201915126
Mar 20195119
Apr 2019191211
May 2019516
Jun 20191458
Jul 20192329
Aug 2019323513
Sep 201910356
Oct 201921819
Nov 20191159
Dec 201914318
Jan 202013916
Feb 202011522
Mar 2020141022
Apr 2020221015
May 202017819
Jun 20202079
Jul 20201476
Aug 2020231111
Sep 202021712
Oct 2020181220
Nov 2020141111
Dec 202010812
Jan 202171010
Feb 2021102126
Mar 202162421
Apr 202142726
May 2021122419
Jun 20216438
Jul 202192617
Aug 202172015
Sep 202141318
Oct 202163029
Nov 202151937
Dec 202182614
Jan 202281814
Feb 202233020
Mar 202253225
Apr 20224615
May 202201919
Jun 202232721
Jul 20223267
Aug 202232317
Sep 202263421
Oct 202244622
Nov 202211613
Dec 202231410
Jan 2023138515
Feb 202392817
Mar 20233246
Apr 20236267
May 202372415
Jun 202362114
Jul 202361711
Aug 202372411
Sep 2023112415
Oct 202331610
Nov 202335417
Dec 2023233214
Jan 20247355
Feb 2024112719
Mar 202431919
Apr 202475722
May 202458610
Jun 2024124018
Jul 2024154226
Aug 202496223
Sep 202465923
Oct 202494219
Nov 202486322
Dec 202456522
Jan 202533216
Feb 2025129219
Mar 2025116132
Apr 2025137023
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 56 (11)
Journal of Nuclear Medicine
Vol. 56, Issue 11
November 1, 2015
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Comparison of 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Comparison of 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma
Molly P. Hogan, Debra A. Goldman, Brittany Dashevsky, Christopher C. Riedl, Mithat Gönen, Joseph R. Osborne, Maxine Jochelson, Clifford Hudis, Monica Morrow, Gary A. Ulaner
Journal of Nuclear Medicine Nov 2015, 56 (11) 1674-1680; DOI: 10.2967/jnumed.115.161455

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Comparison of 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Invasive Lobular Carcinoma Versus Invasive Ductal Carcinoma
Molly P. Hogan, Debra A. Goldman, Brittany Dashevsky, Christopher C. Riedl, Mithat Gönen, Joseph R. Osborne, Maxine Jochelson, Clifford Hudis, Monica Morrow, Gary A. Ulaner
Journal of Nuclear Medicine Nov 2015, 56 (11) 1674-1680; DOI: 10.2967/jnumed.115.161455
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Diagnostic Potential of 68Ga-NeoB PET/CT with Estrogen Receptor- and Progesterone Receptor-Positive Breast Cancer Undergoing Staging or Restaging for Metastatic Disease
  • Oncogenic NOVA1 expression dysregulates alternative splicing in breast cancer
  • 68Ga-FAP-2286 PET of Solid Tumors: Biodistribution, Dosimetry, and Comparison with 18F-FDG
  • 68Ga-FAPI PET/CT as an Alternative to 18F-FDG PET/CT in the Imaging of Invasive Lobular Breast Carcinoma
  • WNT4 regulates cellular metabolism via intracellular activity at the mitochondria in breast and gynecologic cancers
  • Summary: Appropriate Use Criteria for Estrogen Receptor-Targeted PET Imaging with 16{alpha}-18F-Fluoro-17{beta}-Fluoroestradiol
  • WNT4 executes estrogen regulation of cellular metabolism via intracellular activity at the mitochondria
  • Head-to-Head Evaluation of 18F-FES and 18F-FDG PET/CT in Metastatic Invasive Lobular Breast Cancer
  • Mars Shot for Nuclear Medicine, Molecular Imaging, and Molecularly Targeted Radiopharmaceutical Therapy
  • 18F-FDG PET/CT for Systemic Staging of Newly Diagnosed Breast Cancer in Men
  • Expression of Gastrin-Releasing Peptide Receptor in Breast Cancer and Its Association with Pathologic, Biologic, and Clinical Parameters: A Study of 1,432 Primary Tumors
  • Prospective Clinical Trial of 18F-Fluciclovine PET/CT for Determining the Response to Neoadjuvant Therapy in Invasive Ductal and Invasive Lobular Breast Cancers
  • Initial Results of a Prospective Clinical Trial of 18F-Fluciclovine PET/CT in Newly Diagnosed Invasive Ductal and Invasive Lobular Breast Cancers
  • Google Scholar

More in this TOC Section

  • Cardiac Presynaptic Sympathetic Nervous Function Evaluated by Cardiac PET in Patients with Chronotropic Incompetence Without Heart Failure
  • Validation and Evaluation of a Vendor-Provided Head Motion Correction Algorithm on the uMI Panorama PET/CT System
  • Prognostic Role of 68Ga-PSMA11 PET–Based Response in Patients with Prostate Cancer Undergoing Taxane-Based Chemotherapy
Show more Clinical Investigations

Similar Articles

Keywords

  • lobular
  • ductal
  • breast cancer
  • 18F-FDG
  • PET/CT
  • staging
SNMMI

© 2025 SNMMI

Powered by HighWire